메뉴 건너뛰기




Volumn 1832, Issue 12, 2013, Pages 2271-2276

Cardiac matrix: A clue for future therapy

Author keywords

Angiogenesis; Heart; MiRNA; MMP; Stem cell; TIMP

Indexed keywords

5 ETHOXYMETHOXY N HYDROXY 2 METHYL 4 (4 PHENOXYBENZAMIDO)PENTANAMIDE; ANGIOSTATIN; BATIMASTAT; ENDOSTATIN; GELATINASE A; GELATINASE B; ILOMASTAT; MARIMASTAT; MICRORNA; PROTEINASE; REACTIVE OXYGEN METABOLITE; TISSUE INHIBITOR OF METALLOPROTEINASE;

EID: 84884792184     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2013.09.004     Document Type: Review
Times cited : (52)

References (76)
  • 1
    • 33747152561 scopus 로고    scopus 로고
    • Matrix elasticity directs stem cell lineage specification
    • Engler A.J., Sen S., Sweeney H.L., Discher D.E. Matrix elasticity directs stem cell lineage specification. Cell 2006, 126:677-689.
    • (2006) Cell , vol.126 , pp. 677-689
    • Engler, A.J.1    Sen, S.2    Sweeney, H.L.3    Discher, D.E.4
  • 5
    • 80052712758 scopus 로고    scopus 로고
    • Novel microRNA prosurvival cocktail for improving engraftment and function of cardiac progenitor cell transplantation
    • Hu S., Huang M., Nguyen P.K., Gong Y., Li Z., Jia F., Lan F., Liu J., Nag D., Robbins R.C., Wu J.C. Novel microRNA prosurvival cocktail for improving engraftment and function of cardiac progenitor cell transplantation. Circulation 2011, 124:S27-S34.
    • (2011) Circulation , vol.124
    • Hu, S.1    Huang, M.2    Nguyen, P.K.3    Gong, Y.4    Li, Z.5    Jia, F.6    Lan, F.7    Liu, J.8    Nag, D.9    Robbins, R.C.10    Wu, J.C.11
  • 6
    • 80054074560 scopus 로고    scopus 로고
    • Synergy of microRNA and stem cell: a novel therapeutic approach for diabetes mellitus and cardiovascular diseases
    • Tyagi A.C., Sen U., Mishra P.K. Synergy of microRNA and stem cell: a novel therapeutic approach for diabetes mellitus and cardiovascular diseases. Curr. Diabetes Rev. 2011, 7:367-376.
    • (2011) Curr. Diabetes Rev. , vol.7 , pp. 367-376
    • Tyagi, A.C.1    Sen, U.2    Mishra, P.K.3
  • 7
    • 77954135412 scopus 로고    scopus 로고
    • MMP-9 gene ablation and TIMP-4 mitigate PAR-1-mediated cardiomyocyte dysfunction: a plausible role of dicer and miRNA
    • Mishra P.K., Metreveli N., Tyagi S.C. MMP-9 gene ablation and TIMP-4 mitigate PAR-1-mediated cardiomyocyte dysfunction: a plausible role of dicer and miRNA. Cell Biochem. Biophys. 2010, 57:67-76.
    • (2010) Cell Biochem. Biophys. , vol.57 , pp. 67-76
    • Mishra, P.K.1    Metreveli, N.2    Tyagi, S.C.3
  • 8
    • 84858009949 scopus 로고    scopus 로고
    • Ablation of MMP9 induces survival and differentiation of cardiac stem cells into cardiomyocytes in the heart of diabetics: a role of extracellular matrix
    • Mishra P.K., Chavali V., Metreveli N., Tyagi S.C. Ablation of MMP9 induces survival and differentiation of cardiac stem cells into cardiomyocytes in the heart of diabetics: a role of extracellular matrix. Can. J. Physiol. Pharmacol. 2012, 90:353-360.
    • (2012) Can. J. Physiol. Pharmacol. , vol.90 , pp. 353-360
    • Mishra, P.K.1    Chavali, V.2    Metreveli, N.3    Tyagi, S.C.4
  • 10
    • 0027375097 scopus 로고
    • Myocardial matrix metalloproteinase(s): localization and activation
    • Tyagi S.C., Ratajska A., Weber K.T. Myocardial matrix metalloproteinase(s): localization and activation. Mol. Cell. Biochem. 1993, 126:49-59.
    • (1993) Mol. Cell. Biochem. , vol.126 , pp. 49-59
    • Tyagi, S.C.1    Ratajska, A.2    Weber, K.T.3
  • 11
    • 0030584673 scopus 로고    scopus 로고
    • X-ray structure of a hydroxamate inhibitor complex of stromelysin catalytic domain and its comparison with members of the zinc metalloproteinase superfamily
    • Dhanaraj V., Ye Q.Z., Johnson L.L., Hupe D.J., Ortwine D.F., Dunbar J.B., Rubin J.R., Pavlovsky A., Humblet C., Blundell T.L. X-ray structure of a hydroxamate inhibitor complex of stromelysin catalytic domain and its comparison with members of the zinc metalloproteinase superfamily. Structure 1996, 4:375-386.
    • (1996) Structure , vol.4 , pp. 375-386
    • Dhanaraj, V.1    Ye, Q.Z.2    Johnson, L.L.3    Hupe, D.J.4    Ortwine, D.F.5    Dunbar, J.B.6    Rubin, J.R.7    Pavlovsky, A.8    Humblet, C.9    Blundell, T.L.10
  • 15
    • 47249109410 scopus 로고    scopus 로고
    • Mitochondrial MMP activation, dysfunction and arrhythmogenesis in hyperhomocysteinemia
    • Moshal K.S., Metreveli N., Frank I., Tyagi S.C. Mitochondrial MMP activation, dysfunction and arrhythmogenesis in hyperhomocysteinemia. Curr. Vasc. Pharmacol. 2008, 6:84-92.
    • (2008) Curr. Vasc. Pharmacol. , vol.6 , pp. 84-92
    • Moshal, K.S.1    Metreveli, N.2    Frank, I.3    Tyagi, S.C.4
  • 17
    • 8544240184 scopus 로고    scopus 로고
    • Brg-1 is required for maximal transcription of the human matrix metalloproteinase-2 gene
    • Ma Z., Chang M.J., Shah R., Adamski J., Zhao X., Benveniste E.N. Brg-1 is required for maximal transcription of the human matrix metalloproteinase-2 gene. J. Biol. Chem. 2004, 279:46326-46334.
    • (2004) J. Biol. Chem. , vol.279 , pp. 46326-46334
    • Ma, Z.1    Chang, M.J.2    Shah, R.3    Adamski, J.4    Zhao, X.5    Benveniste, E.N.6
  • 18
    • 0032857460 scopus 로고    scopus 로고
    • The transcription factors Sp1, Sp3, and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells
    • Qin H., Sun Y., Benveniste E.N. The transcription factors Sp1, Sp3, and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells. J. Biol. Chem. 1999, 274:29130-29137.
    • (1999) J. Biol. Chem. , vol.274 , pp. 29130-29137
    • Qin, H.1    Sun, Y.2    Benveniste, E.N.3
  • 19
    • 43949113620 scopus 로고    scopus 로고
    • Increased activities of cardiac matrix metalloproteinases matrix metalloproteinase (MMP)-2 and MMP-9 are associated with mortality during the acute phase of experimental Trypanosoma cruzi infection
    • Gutierrez F.R., Lalu M.M., Mariano F.S., Milanezi C.M., Cena J., Gerlach R.F., Santos J.E., Torres-Duenas D., Cunha F.Q., Schulz R., Silva J.S. Increased activities of cardiac matrix metalloproteinases matrix metalloproteinase (MMP)-2 and MMP-9 are associated with mortality during the acute phase of experimental Trypanosoma cruzi infection. J. Infect. Dis. 2008, 197:1468-1476.
    • (2008) J. Infect. Dis. , vol.197 , pp. 1468-1476
    • Gutierrez, F.R.1    Lalu, M.M.2    Mariano, F.S.3    Milanezi, C.M.4    Cena, J.5    Gerlach, R.F.6    Santos, J.E.7    Torres-Duenas, D.8    Cunha, F.Q.9    Schulz, R.10    Silva, J.S.11
  • 22
    • 84859229746 scopus 로고    scopus 로고
    • A novel intracellular isoform of matrix metalloproteinase-2 induced by oxidative stress activates innate immunity
    • Lovett D.H., Mahimkar R., Raffai R.L., Cape L., Maklashina E., Cecchini G., Karliner J.S. A novel intracellular isoform of matrix metalloproteinase-2 induced by oxidative stress activates innate immunity. PLoS One 2012, 7:e34177.
    • (2012) PLoS One , vol.7
    • Lovett, D.H.1    Mahimkar, R.2    Raffai, R.L.3    Cape, L.4    Maklashina, E.5    Cecchini, G.6    Karliner, J.S.7
  • 23
    • 0034680304 scopus 로고    scopus 로고
    • Matrix matters
    • Libby P., Lee R.T. Matrix matters. Circulation 2000, 102:1874-1876.
    • (2000) Circulation , vol.102 , pp. 1874-1876
    • Libby, P.1    Lee, R.T.2
  • 24
    • 0035902456 scopus 로고    scopus 로고
    • Current concepts of the pathogenesis of the acute coronary syndromes
    • Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 2001, 104:365-372.
    • (2001) Circulation , vol.104 , pp. 365-372
    • Libby, P.1
  • 25
    • 84861919257 scopus 로고    scopus 로고
    • Tissue inhibitor of metalloproteinases (TIMP-1), genetic markers of insulin resistance and cardiomyopathy in patients with kidney failure
    • Spoto B., Testa A., Parlongo R.M., Tripepi G., D'Arrigo G., Mallamaci F., Zoccali C. Tissue inhibitor of metalloproteinases (TIMP-1), genetic markers of insulin resistance and cardiomyopathy in patients with kidney failure. Nephrol. Dial. Transplant. 2012, 27:2440-2445.
    • (2012) Nephrol. Dial. Transplant. , vol.27 , pp. 2440-2445
    • Spoto, B.1    Testa, A.2    Parlongo, R.M.3    Tripepi, G.4    D'Arrigo, G.5    Mallamaci, F.6    Zoccali, C.7
  • 26
    • 80052730897 scopus 로고    scopus 로고
    • An integrin-binding N-terminal peptide region of TIMP-2 retains potent angio-inhibitory and anti-tumorigenic activity in vivo
    • Seo D.W., Saxinger W.C., Guedez L., Cantelmo A.R., Albini A., Stetler-Stevenson W.G. An integrin-binding N-terminal peptide region of TIMP-2 retains potent angio-inhibitory and anti-tumorigenic activity in vivo. Peptides 2011, 32:1840-1848.
    • (2011) Peptides , vol.32 , pp. 1840-1848
    • Seo, D.W.1    Saxinger, W.C.2    Guedez, L.3    Cantelmo, A.R.4    Albini, A.5    Stetler-Stevenson, W.G.6
  • 28
    • 78650606524 scopus 로고    scopus 로고
    • TIMP-3 promotes apoptosis in nonadherent small cell lung carcinoma cells lacking functional death receptor pathway
    • Kallio J.P., Hopkins-Donaldson S., Baker A.H., Kahari V.M. TIMP-3 promotes apoptosis in nonadherent small cell lung carcinoma cells lacking functional death receptor pathway. Int. J. Cancer 2011, 128:991-996.
    • (2011) Int. J. Cancer , vol.128 , pp. 991-996
    • Kallio, J.P.1    Hopkins-Donaldson, S.2    Baker, A.H.3    Kahari, V.M.4
  • 29
    • 33746902022 scopus 로고    scopus 로고
    • In vitro susceptibility to the pro-apoptotic effects of TIMP-3 gene delivery translates to greater in vivo efficacy versus gene delivery for TIMPs-1 or -2
    • Finan K.M., Hodge G., Reynolds A.M., Hodge S., Holmes M.D., Baker A.H., Reynolds P.N. In vitro susceptibility to the pro-apoptotic effects of TIMP-3 gene delivery translates to greater in vivo efficacy versus gene delivery for TIMPs-1 or -2. Lung Cancer 2006, 53:273-284.
    • (2006) Lung Cancer , vol.53 , pp. 273-284
    • Finan, K.M.1    Hodge, G.2    Reynolds, A.M.3    Hodge, S.4    Holmes, M.D.5    Baker, A.H.6    Reynolds, P.N.7
  • 31
    • 33646439273 scopus 로고    scopus 로고
    • Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease
    • Ahmed S.H., Clark L.L., Pennington W.R., Webb C.S., Bonnema D.D., Leonardi A.H., McClure C.D., Spinale F.G., Zile M.R. Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease. Circulation 2006, 113:2089-2096.
    • (2006) Circulation , vol.113 , pp. 2089-2096
    • Ahmed, S.H.1    Clark, L.L.2    Pennington, W.R.3    Webb, C.S.4    Bonnema, D.D.5    Leonardi, A.H.6    McClure, C.D.7    Spinale, F.G.8    Zile, M.R.9
  • 32
    • 84874404425 scopus 로고    scopus 로고
    • Membrane-associated matrix proteolysis and heart failure
    • Spinale F.G., Janicki J.S., Zile M.R. Membrane-associated matrix proteolysis and heart failure. Circ. Res. 2013, 112:195-208.
    • (2013) Circ. Res. , vol.112 , pp. 195-208
    • Spinale, F.G.1    Janicki, J.S.2    Zile, M.R.3
  • 35
    • 84870920351 scopus 로고    scopus 로고
    • Temporal changes in cardiac matrix metalloproteinase activity, oxidative stress, and TGF-beta in renovascular hypertension-induced cardiac hypertrophy
    • Rizzi E., Ceron C.S., Guimaraes D.A., Prado C.M., Rossi M.A., Gerlach R.F., Tanus-Santos J.E. Temporal changes in cardiac matrix metalloproteinase activity, oxidative stress, and TGF-beta in renovascular hypertension-induced cardiac hypertrophy. Exp. Mol. Pathol. 2013, 94:1-9.
    • (2013) Exp. Mol. Pathol. , vol.94 , pp. 1-9
    • Rizzi, E.1    Ceron, C.S.2    Guimaraes, D.A.3    Prado, C.M.4    Rossi, M.A.5    Gerlach, R.F.6    Tanus-Santos, J.E.7
  • 38
    • 84876734919 scopus 로고    scopus 로고
    • Matrix metalloproteinases as drug targets in acute pulmonary embolism
    • Neto-Neves E.M., Kiss T., Muhl D., Tanus-Santos J.E. Matrix metalloproteinases as drug targets in acute pulmonary embolism. Curr. Drug Targets 2013, 14:344-352.
    • (2013) Curr. Drug Targets , vol.14 , pp. 344-352
    • Neto-Neves, E.M.1    Kiss, T.2    Muhl, D.3    Tanus-Santos, J.E.4
  • 41
    • 80054113262 scopus 로고    scopus 로고
    • Matrix metalloproteinase inhibitor properties of tetracyclines: therapeutic potential in cardiovascular diseases
    • Castro M.M., Kandasamy A.D., Youssef N., Schulz R. Matrix metalloproteinase inhibitor properties of tetracyclines: therapeutic potential in cardiovascular diseases. Pharmacol. Res. 2011, 64:551-560.
    • (2011) Pharmacol. Res. , vol.64 , pp. 551-560
    • Castro, M.M.1    Kandasamy, A.D.2    Youssef, N.3    Schulz, R.4
  • 42
    • 0034018680 scopus 로고    scopus 로고
    • ONO-4817, an orally active matrix metalloproteinase inhibitor, prevents lipopolysaccharide-induced proteoglycan release from the joint cartilage in guinea pigs
    • Yamada A., Uegaki A., Nakamura T., Ogawa K. ONO-4817, an orally active matrix metalloproteinase inhibitor, prevents lipopolysaccharide-induced proteoglycan release from the joint cartilage in guinea pigs. Inflamm. Res. 2000, 49:144-146.
    • (2000) Inflamm. Res. , vol.49 , pp. 144-146
    • Yamada, A.1    Uegaki, A.2    Nakamura, T.3    Ogawa, K.4
  • 43
    • 0023245356 scopus 로고
    • A non-antibacterial chemically-modified tetracycline inhibits mammalian collagenase activity
    • Golub L.M., McNamara T.F., D'Angelo G., Greenwald R.A., Ramamurthy N.S. A non-antibacterial chemically-modified tetracycline inhibits mammalian collagenase activity. J. Dent. Res. 1987, 66:1310-1314.
    • (1987) J. Dent. Res. , vol.66 , pp. 1310-1314
    • Golub, L.M.1    McNamara, T.F.2    D'Angelo, G.3    Greenwald, R.A.4    Ramamurthy, N.S.5
  • 44
    • 79251612333 scopus 로고    scopus 로고
    • Antimicrobial and non-antimicrobial tetracyclines in human cancer trials
    • Richards C., Pantanowitz L., Dezube B.J. Antimicrobial and non-antimicrobial tetracyclines in human cancer trials. Pharmacol. Res. 2011, 63:151-156.
    • (2011) Pharmacol. Res. , vol.63 , pp. 151-156
    • Richards, C.1    Pantanowitz, L.2    Dezube, B.J.3
  • 45
    • 0347444723 scopus 로고    scopus 로고
    • MicroRNAs: genomics, biogenesis, mechanism, and function
    • Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
    • (2004) Cell , vol.116 , pp. 281-297
    • Bartel, D.P.1
  • 46
    • 58249088751 scopus 로고    scopus 로고
    • MicroRNAs: target recognition and regulatory functions
    • Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
    • (2009) Cell , vol.136 , pp. 215-233
    • Bartel, D.P.1
  • 47
    • 65249156118 scopus 로고    scopus 로고
    • MicroRNAs as a therapeutic target for cardiovascular diseases
    • Mishra P.K., Tyagi N., Kumar M., Tyagi S.C. MicroRNAs as a therapeutic target for cardiovascular diseases. J. Cell. Mol. Med. 2009, 13:778-789.
    • (2009) J. Cell. Mol. Med. , vol.13 , pp. 778-789
    • Mishra, P.K.1    Tyagi, N.2    Kumar, M.3    Tyagi, S.C.4
  • 49
    • 0031040522 scopus 로고    scopus 로고
    • Proteinases and myocardial extracellular matrix turnover
    • Tyagi S.C. Proteinases and myocardial extracellular matrix turnover. Mol. Cell. Biochem. 1997, 168:1-12.
    • (1997) Mol. Cell. Biochem. , vol.168 , pp. 1-12
    • Tyagi, S.C.1
  • 51
    • 33845485056 scopus 로고    scopus 로고
    • A quantitative gene expression profile of matrix metalloproteinases (MMPS) and their inhibitors (TIMPS) in the myocardium of patients with deteriorating heart failure requiring left ventricular assist device support
    • Felkin L.E., Birks E.J., George R., Wong S., Khaghani A., Yacoub M.H., Barton P.J. A quantitative gene expression profile of matrix metalloproteinases (MMPS) and their inhibitors (TIMPS) in the myocardium of patients with deteriorating heart failure requiring left ventricular assist device support. J. Heart Lung Transplant. 2006, 25:1413-1419.
    • (2006) J. Heart Lung Transplant. , vol.25 , pp. 1413-1419
    • Felkin, L.E.1    Birks, E.J.2    George, R.3    Wong, S.4    Khaghani, A.5    Yacoub, M.H.6    Barton, P.J.7
  • 55
    • 74049096307 scopus 로고    scopus 로고
    • MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts
    • Matkovich S.J., Wang W., Tu Y., Eschenbacher W.H., Dorn L.E., Condorelli G., Diwan A., Nerbonne J.M., Dorn G.W. MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts. Circ. Res. 2010, 106:166-175.
    • (2010) Circ. Res. , vol.106 , pp. 166-175
    • Matkovich, S.J.1    Wang, W.2    Tu, Y.3    Eschenbacher, W.H.4    Dorn, L.E.5    Condorelli, G.6    Diwan, A.7    Nerbonne, J.M.8    Dorn, G.W.9
  • 56
    • 84865565944 scopus 로고    scopus 로고
    • MicroRNA-133a regulates DNA methylation in diabetic cardiomyocytes
    • Chavali V., Tyagi S.C., Mishra P.K. MicroRNA-133a regulates DNA methylation in diabetic cardiomyocytes. Biochem. Biophys. Res. Commun. 2012, 425:668-672.
    • (2012) Biochem. Biophys. Res. Commun. , vol.425 , pp. 668-672
    • Chavali, V.1    Tyagi, S.C.2    Mishra, P.K.3
  • 58
    • 77954968089 scopus 로고    scopus 로고
    • Acellular cardiac extracellular matrix as a scaffold for tissue engineering: in vitro cell support, remodeling, and biocompatibility
    • Eitan Y., Sarig U., Dahan N., Machluf M. Acellular cardiac extracellular matrix as a scaffold for tissue engineering: in vitro cell support, remodeling, and biocompatibility. Tissue Eng. Part C Methods 2010, 16:671-683.
    • (2010) Tissue Eng. Part C Methods , vol.16 , pp. 671-683
    • Eitan, Y.1    Sarig, U.2    Dahan, N.3    Machluf, M.4
  • 59
    • 33645738381 scopus 로고    scopus 로고
    • Vascular endothelial growth factor delays onset of failure in pressure-overload hypertrophy through matrix metalloproteinase activation and angiogenesis
    • Friehs I., Margossian R.E., Moran A.M., Cao-Danh H., Moses M.A., del Nido P.J. Vascular endothelial growth factor delays onset of failure in pressure-overload hypertrophy through matrix metalloproteinase activation and angiogenesis. Basic Res. Cardiol. 2006, 101:204-213.
    • (2006) Basic Res. Cardiol. , vol.101 , pp. 204-213
    • Friehs, I.1    Margossian, R.E.2    Moran, A.M.3    Cao-Danh, H.4    Moses, M.A.5    del Nido, P.J.6
  • 60
    • 0032160033 scopus 로고    scopus 로고
    • Complex role of matrix metalloproteinases in angiogenesis
    • Sang Q.X. Complex role of matrix metalloproteinases in angiogenesis. Cell Res. 1998, 8:171-177.
    • (1998) Cell Res. , vol.8 , pp. 171-177
    • Sang, Q.X.1
  • 61
    • 0010712792 scopus 로고    scopus 로고
    • Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity
    • Brooks P.C., Silletti S., von Schalscha T.L., Friedlander M., Cheresh D.A. Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity. Cell 1998, 92:391-400.
    • (1998) Cell , vol.92 , pp. 391-400
    • Brooks, P.C.1    Silletti, S.2    von Schalscha, T.L.3    Friedlander, M.4    Cheresh, D.A.5
  • 63
    • 61949477290 scopus 로고    scopus 로고
    • Endostatin and angiostatin are increased in diabetic patients with coronary artery disease and associated with impaired coronary collateral formation
    • Sodha N.R., Clements R.T., Boodhwani M., Xu S.H., Laham R.J., Bianchi C., Sellke F.W. Endostatin and angiostatin are increased in diabetic patients with coronary artery disease and associated with impaired coronary collateral formation. Am. J. Physiol. Heart Circ. Physiol. 2009, 296:H428-H434.
    • (2009) Am. J. Physiol. Heart Circ. Physiol. , vol.296
    • Sodha, N.R.1    Clements, R.T.2    Boodhwani, M.3    Xu, S.H.4    Laham, R.J.5    Bianchi, C.6    Sellke, F.W.7
  • 64
    • 0033517733 scopus 로고    scopus 로고
    • Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled trial
    • Laham R.J., Sellke F.W., Edelman E.R., Pearlman J.D., Ware J.A., Brown D.L., Gold J.P., Simons M. Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled trial. Circulation 1999, 100:1865-1871.
    • (1999) Circulation , vol.100 , pp. 1865-1871
    • Laham, R.J.1    Sellke, F.W.2    Edelman, E.R.3    Pearlman, J.D.4    Ware, J.A.5    Brown, D.L.6    Gold, J.P.7    Simons, M.8
  • 65
    • 0033503798 scopus 로고    scopus 로고
    • Six-month assessment of a phase I trial of angiogenic gene therapy for the treatment of coronary artery disease using direct intramyocardial administration of an adenovirus vector expressing the VEGF121 cDNA
    • Rosengart T.K., Lee L.Y., Patel S.R., Kligfield P.D., Okin P.M., Hackett N.R., Isom O.W., Crystal R.G. Six-month assessment of a phase I trial of angiogenic gene therapy for the treatment of coronary artery disease using direct intramyocardial administration of an adenovirus vector expressing the VEGF121 cDNA. Ann. Surg. 1999, 230:466-470.
    • (1999) Ann. Surg. , vol.230 , pp. 466-470
    • Rosengart, T.K.1    Lee, L.Y.2    Patel, S.R.3    Kligfield, P.D.4    Okin, P.M.5    Hackett, N.R.6    Isom, O.W.7    Crystal, R.G.8
  • 66
    • 0032562232 scopus 로고    scopus 로고
    • Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease
    • Schumacher B., Pecher P., von Specht B.U., Stegmann T. Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease. Circulation 1998, 97:645-650.
    • (1998) Circulation , vol.97 , pp. 645-650
    • Schumacher, B.1    Pecher, P.2    von Specht, B.U.3    Stegmann, T.4
  • 67
    • 23644439061 scopus 로고    scopus 로고
    • Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure
    • Shiojima I., Sato K., Izumiya Y., Schiekofer S., Ito M., Liao R., Colucci W.S., Walsh K. Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J. Clin. Invest. 2005, 115:2108-2118.
    • (2005) J. Clin. Invest. , vol.115 , pp. 2108-2118
    • Shiojima, I.1    Sato, K.2    Izumiya, Y.3    Schiekofer, S.4    Ito, M.5    Liao, R.6    Colucci, W.S.7    Walsh, K.8
  • 69
  • 70
    • 84868281147 scopus 로고    scopus 로고
    • Relationship between endothelial-to-mesenchymal transition and cardiac fibrosis in acute viral myocarditis
    • Hua J.Y., Zhang Z.C., Jiang X.H., He Y.Z., Chen P. Relationship between endothelial-to-mesenchymal transition and cardiac fibrosis in acute viral myocarditis. Zhejiang Da Xue Xue Bao Yi Xue Ban 2012, 41:298-304.
    • (2012) Zhejiang Da Xue Xue Bao Yi Xue Ban , vol.41 , pp. 298-304
    • Hua, J.Y.1    Zhang, Z.C.2    Jiang, X.H.3    He, Y.Z.4    Chen, P.5
  • 71
    • 67650999875 scopus 로고    scopus 로고
    • The basics of epithelial-mesenchymal transition
    • Kalluri R., Weinberg R.A. The basics of epithelial-mesenchymal transition. J. Clin. Invest. 2009, 119:1420-1428.
    • (2009) J. Clin. Invest. , vol.119 , pp. 1420-1428
    • Kalluri, R.1    Weinberg, R.A.2
  • 73
    • 0036854980 scopus 로고    scopus 로고
    • Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy
    • Yang J., Shultz R.W., Mars W.M., Wegner R.E., Li Y., Dai C., Nejak K., Liu Y. Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy. J. Clin. Invest. 2002, 110:1525-1538.
    • (2002) J. Clin. Invest. , vol.110 , pp. 1525-1538
    • Yang, J.1    Shultz, R.W.2    Mars, W.M.3    Wegner, R.E.4    Li, Y.5    Dai, C.6    Nejak, K.7    Liu, Y.8
  • 74
    • 36749100945 scopus 로고    scopus 로고
    • A new gaseous signaling molecule emerges: cardioprotective role of hydrogen sulfide
    • Lefer D.J. A new gaseous signaling molecule emerges: cardioprotective role of hydrogen sulfide. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:17907-17908.
    • (2007) Proc. Natl. Acad. Sci. U.S.A. , vol.104 , pp. 17907-17908
    • Lefer, D.J.1
  • 75
    • 84857944770 scopus 로고    scopus 로고
    • Hydrogen sulfide mitigates cardiac remodeling during myocardial infarction via improvement of angiogenesis
    • Qipshidze N., Metreveli N., Mishra P.K., Lominadze D., Tyagi S.C. Hydrogen sulfide mitigates cardiac remodeling during myocardial infarction via improvement of angiogenesis. Int. J. Biol. Sci. 2012, 8:430-441.
    • (2012) Int. J. Biol. Sci. , vol.8 , pp. 430-441
    • Qipshidze, N.1    Metreveli, N.2    Mishra, P.K.3    Lominadze, D.4    Tyagi, S.C.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.